Skip to main content
Signal8

Wei Lin

SEC insider (Form 3/4/5 filer). CIK 0001872772. Director at TCGX Acquisition Corp. (TCGX) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 17, 2026. Located in REDWOOD CITY, CA.

Companies Wei Lin has filed insider reports for

  • TCGX Acquisition Corp. (TCGX): Director
  • Revolution Medicines, Inc. (RVMD): Officer, Chief Medical Officer
  • 2seventy bio, Inc. (TSVT): Director
Wei Lin profile photo

Wei Lin

CIK: 0001872772

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (42.9%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

TCGX Acquisition Corp. logo
TCGX

TCGX Acquisition Corp.

Director
Revolution Medicines, Inc. logo
RVMD

Revolution Medicines, Inc.

Officer
2seventy bio, Inc. logo
TSVT

2seventy bio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Revolution Medicines, Inc. logo
    RVMD

    Revolution Medicines, Inc.

    Mar 17, 2026
    Sale
    Direct
    2.1K shares at avg. $99.48$206K
  • Revolution Medicines, Inc. logo
    RVMD

    Revolution Medicines, Inc.

    Mar 1, 2026
    Award
    Direct
    15.1K shares-
  • Revolution Medicines, Inc. logo
    RVMD

    Revolution Medicines, Inc.

    Sep 16, 2025
    Sale
    Direct
    2.2K shares at avg. $45.82$99K
  • Revolution Medicines, Inc. logo
    RVMD

    Revolution Medicines, Inc.

    Jun 16, 2025
    Sale
    Direct
    2.2K shares at avg. $39.83$87K
  • 2seventy bio, Inc. logo
    TSVT

    2seventy bio, Inc.

    May 13, 2025
    Disposition
    Direct
    17.6K shares-
  • 2seventy bio, Inc. logo
    TSVT

    2seventy bio, Inc.

    May 13, 2025
    Tender Offer
    Direct
    15.3K shares-
  • Revolution Medicines, Inc. logo
    RVMD

    Revolution Medicines, Inc.

    Mar 1, 2025
    Award
    Direct
    20.8K shares-

1-7 of 7